Besides CD4 TRM cells, whether CD8 TRM cells could contribute to the development of chronic lung sequelae following COVID-19 during aging, as what have demonstrated in influenza pneumonia model [67], requires further investigation. This evidence concerns the gene CD8A and COVID-19.